CD14 targeted DK4/10 (Deka Biosciences)

N/A

Report date: 2025/01/26 19:30:41

Base Information

Drug NameCD14 targeted DK4/10 (Deka Biosciences)

Drug Alias NameCD14 targeted therapeutic (Deka Biosciences Inc)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionMonocyte differentiation antigen CD14 modulatorsInterleukin-10 modulatorsInterleukin-4 modulators

TargetsMonocyte differentiation antigen CD14Interleukin-4Interleukin-10

Therapy Area/IndicationsSepsis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSepsis

Inactive IndicationsN/A

ATC CodeN/A